红日药业 (300026)
Tianjin Chase Sun Pharmaceutical Co., Ltd.
K-Line Chart
No K-line data available
Company NameTianjin Chase Sun Pharmaceutical Co., Ltd.
Listing Date2009-10-30
Issue Price60RMB
Registered Capital300415.483710k RMB
Legal RepresentativeWu Wenyuan
Registered AddressWest of Quanfa Road, Wuqing Development Zone, Tianjin New Technology Industrial Park
IndustryTraditional Chinese Medicine II
Main BusinessProduction, operation, research and development of pharmaceuticals and medical devices.
Company ProfileTianjin Chase Sun Pharmaceutical Co., Ltd. (abbreviated as Chase Sun Pharmaceutical, stock code 300026) was founded in 1996 and is located in Wuqing Development Zone, Tianjin. It has now developed into a high-tech pharmaceutical and health industry group spanning modern traditional Chinese medicine, chemical synthetic drugs, biotechnology drugs, pharmaceutical excipients and APIs, medical devices, medical services, and many other fields. It integrates investment and financing, R&D, production, and sales, with over forty subsidiaries.
Stock Details
1. Key Indicators
- Total Shares(W): 300415.48
- Circulating A-Shares(W): 273852.85
- Earnings Per Share(RMB): 0.0300
- Net Assets Per Share(RMB): 2.8755
- Operating Revenue(W RMB): 414856.29
- Total Profit(W RMB): 14120.01
- Net Profit Attributable to Parent(W RMB): 8076.29
- Net Profit Growth Rate(%): -52.03
- Weighted Return on Equity(%): 0.9300
- Operating Cash Flow Per Share(RMB): 0.1790
- Undistributed Profit Per Share(RMB): 1.5759
- Capital Reserve Per Share(RMB): 0.1964
2. Main Business
The main business covers:
- Traditional Chinese Medicine Formula Granules
- Finished Drugs
- Medical Devices
- Raw and Auxiliary Materials
- Medical and Health Services
- Intelligent Supply Chain for Drugs and Medical Devices
3. Company Basic Information
- Company Name: Tianjin Chasesun Pharmaceutical Co., Ltd.
- Listing Date: 2009-10-30
- Industry: Pharmaceutical Manufacturing
- Address: Building B01, Chuangye Headquarters Base, Wuqing Development Zone, Tianjin
- Website: www.chasesun.cn
- Company Profile: The company was established as a joint stock limited company through the overall change of Tianjin Datong Chasesun Pharmaceutical Co., Ltd., approved by the Tianjin Municipal People's Government and based on the audited net assets as of August 31, 2000. It completed its industrial and commercial registration with the Tianjin Administration for Industry and Commerce on September 30, 2000.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Chengdu Xingcheng Investment Group Co., Ltd. | General Legal Person | 66799.74 | 24.39 |
| 2 | Tianjin Datong Investment Group Co., Ltd. | General Legal Person | 6803.64 | 2.48 |
| 3 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 2121.67 | 0.77 |
| 4 | Zhaoqing Hongli Real Estate Development Co., Ltd. | General Legal Person | 2112.15 | 0.77 |
| 5 | Southern China Securities CSI 1000 ETF | Fund | 1922.70 | 0.70 |
5. Concept Sectors
- Aged Care Concept
- Smart Healthcare
- Pulse Oximeter
- Innovative Drugs
- Margin Trading & Securities Lending
- Intended Reduction
- ChiNext 300
- ChiNext Healthcare
- ChiNext 200
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information